Chris Hall of Vertex explains how e-invoicing is becoming essential for multinational businesses, enabling compliance, operational efficiency, and friction-free participation in global trade amid incr ...
The flaw, dubbed ‘GeminiJack,’ exploits the trust boundary between user-controlled content in data sources and the AI model’s ...
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
One fund just doubled down on a beaten-down tax-tech leader—here’s what they may be seeing that the market isn’t.
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
Harding Loevner, an asset management company, released its “Global Equity Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) caught the attention of investors this week as Morgan Stanley analyst Terence Flynn upgraded the stock to an “Overweight” rating o. Coupled with an ...
Vertex Pharmaceuticals Incorporated ( VRTX) Citi Annual Global Healthcare Conference 2025 December 3, 2025 9:00 AM EST ...
Four innovative projects emerged victorious from the Grand Finale of Green Future Innovation Challenge (GFIC) 2025 in ...
Vertex stock reached a 52-week low, touching 19.17 USD, marking a significant downturn for the company. Over the past year, Vertex has experienced a steep decline, with its stock value plummeting by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback